ISDS Case Map
medicines
The Free Trade Agreement or the Association Agreement the European Union is promoting with two of the four countries member of the Andean Community of Nations (CAN) risks the continuity of this bloc, but it also represents a threat to access to medications and health of the Andean peoples.
The proposed EU-Asean free trade policy on intellectual property rights protection is too sweeping, says a consumer group.
A consumers' group on Saturday urged the Association of Southeast Asian Nations (Asean) to turn down the EU-Asean free trade policy on intellectual property rights protection which, if ratified, could affect the Asean agriculture, biodiversity and public health access.
Efforts by the European Union to insert strong provisions on pharmaceutical patents in free trade agreements it is negotiating with India, Colombia, Peru and ASEAN could imperil access to medicines in developing countries, global public health activists have alleged.
India is set to ask Japan to facilitate the entry of Indian pharmaceutical companies in the world's second-largest drug market. The matter will be raised when the two sides discuss a bilateral comprehensive economic partnership agreement.
This new publication from Health Action International critically reviews the European proposals on intellectual property and discusses the impact they will have on access to essential medicines in the CAN countries.
FTAs often include intellectual property protection that is stronger than the World Trade Organisation requires (known as ‘TRIPS-plus' protection). This book highlights the likely effects on developing countries of agreeing to these TRIPS-plus provisions, particularly those in US FTAs.
The negotiations for the India-Japan Comprehensive Economic Partnership Agreement (CEPA) have gained momentum with the two sides moving towards a deal on allowing Indian companies that make low-cost drugs to sell in Japan.
Fearful fo the ongoing to realize a single market for the Association of Southeast Asian Nations by 2015, Filipino-owned pharmaceutical firms have asked the government to ensure that safety nets are in place for the local industry. Some are more concerned about the India-ASEAN FTA.
Fearful of the ongoing effort to realize a single market for the Association of Southeast Asian Nations by 2015, Filipino-owned pharmaceutical firms have asked the government to ensure that safety nets are in place for the local industry.
